Evaluation of Hearing Aid Benefit

Sonova AG1 site in 1 country15 target enrollmentJanuary 18, 2022

ConditionsHearing Loss, Sensorineural

Overview

Phase: N/A
Intervention: Not specified
Conditions: Hearing Loss, Sensorineural
Sponsor: Sonova AG
Enrollment: 15
Locations: 1
Primary Endpoint: Speech Intelligibility in Quiet.
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.

Registry

clinicaltrials.gov

Start Date

January 18, 2022

End Date

March 4, 2022

Last Updated

2 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Sonova AG

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Moderate to moderately severe sensorineural hearing loss
•Willingness to wear custom hearing instruments during the study.
•Age-normal cognition
•Ability to attend on-site study visits.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Speech Intelligibility in Quiet.

Time Frame: Day 1 and Day 15

Speech intelligibility for monosyllabic words presented in quiet. The words are presented at a fixed level and the percentage of words correctly repeated is calculated. A higher percentage is better. This was done in both unaided and aided conditions.